[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337113-105":59,"doc-detail-337113-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","oncometabolites-at-the-crossroads-of-genetic-epigenetic-and-ecological-alterations-in-cancer","Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer","","Cancer formation involves substantial cell loss, yet tumors progress to clinical detectability, implying selection and evolving trajectories shaped by environmental pressure. Tumor evolvability depends on heterogeneity across genetic, epigenetic, and ecological (microenvironmental) levels, summarized by Evo and Eco indexes. Metabolic alterations uniquely connect Evo and Eco via oncometabolites, which both modulate microenvironment and induce cell-autonomous genetic and epigenetic changes. This review summarizes mechanisms, roles in evolvability, and evolutionary perspective, plus key open questions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncometabolites-at-the-crossroads-of-genetic-epigenetic-and-ecological-alterations-in-cancer/337113/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncometabolites-at-the-crossroads-of-genetic-epigenetic-and-ecological-alterations-in-cancer/337113.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What do the Evo and Eco indexes describe in cancer evolvability?","Question",{"text":113,"@type":114},"The Evo index addresses cancer cell-autonomous heterogeneity at genetic and epigenetic levels. The Eco index describes the ecological landscape, including hazards to survival and available resources in the microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do oncometabolites connect genetic, epigenetic, and ecological alterations?",{"text":118,"@type":114},"Altered metabolism leads to accumulation of oncometabolites that were first viewed as mediators of microenvironmental changes. They are now recognized as inducers of genetic and epigenetic modifications, uniquely linking Evo and Eco components.",{"name":120,"@type":111,"acceptedAnswer":121},"Which oncometabolites are emphasized, and how do they arise?",{"text":122,"@type":114},"The review focuses on lactate (L and D), fumarate, succinate, and 2-hydroxyglutarate (L and D). They originate from perturbations in energy-producing metabolism, such as glycolysis and the TCA cycle, driven by oncogenes or tumor suppressors and metabolic enzyme alterations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337113,1790380050,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","[www.nature.com/cdd](www.nature.com/cdd)  \nREVIEW ARTICLE OPEN   \nOncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer  \nLetizia Lanzetti 1,2 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | By the time a tumor reaches clinical detectability, it contains around 108–109 cells. However, during tumor formation, signiﬁcant cell loss occurs due to cell death. In some estimates, it could take up to a thousand cell generations, over a ~ 20-year life-span of a tumor, to reach clinical detectability, which would correspond to a “theoretical” generation of ~1030 cells. These rough calculations indicate that cancers are under negative selection. The fact that they thrive implies that they “evolve”, and that their evolutionary trajectories are shaped by the pressure of the environment. Evolvability of a cancer is a function of its heterogeneity, which could be at the genetic, epigenetic, and ecological/microenvironmental levels [1] . These principles were summarized in a proposed classiﬁcation in which Evo (evolutionary) and Eco (ecological) indexes are used to label cancers [1] . The Evo index addresses cancer cell-autonomous heterogeneity (genetic/epigenetic) . The Eco index describes the ecological landscape (non-cell-autonomous) in terms of hazards to cancer survival and resources available. The reciprocal inﬂuence of Evo and Eco components is critical, as it can trigger self-sustaining loops that shape cancer evolvability [2] . Among the various hallmarks of cancer [3], metabolic alterations appear unique in that they intersect with both Evo and Eco components. This is partly because altered metabolism leads to the accumulation of oncometabolites. These oncometabolites have traditionally been viewed as mediators of non-cell-autonomous alterations in the cancer microenvironment. However, they are now increasingly recognized as inducers of genetic and epigenetic modiﬁcations. Thus, oncometabolites are uniquely positioned at the crossroads of genetic, epigenetic and ecological alterations in cancer. In this review, the mechanisms of action of oncometabolites will be summarized, together with their roles in the Evo and Eco phenotypic components of cancer evolvability. An evolutionary perspective of the impact of oncometabolites on the natural |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| history of cancer will be presented. |  |  |\n|  | Cell Death & Differentiation (2024) 31:1582–1594; [https://doi.org/10.1038/s41418-024-01402-6](https://doi.org/10.1038/s41418-024-01402-6) |  |\n|  |  |  |\n\nFACTS  \n● Oncometabolites induce modiﬁcations in the cancer microenvironment increasing cancer ﬁtness by minimizing hazardsand allowing exploitation of resources.  \n● Oncometabolites also induce variations in cancer cells (genetic and epigenetic), providing cancer cell-autonomous selectable advantages.  \n● Cell-autonomous and non-cell-autonomous oncometabolitedriven phenotypes cooperate to shape cancer evolvability asan “organoid”.  \nOPEN QUESTIONS  \n● Do oncometabolites recapitulate the effects of the upstream metabolic lesions?  \n● Can oncometabolites induce genetic variations in normal cells of the tumor microenvironment?  \n● Do oncometabolites play different roles in the natural history of cancer, e.g., in the initiation vs. the progression phase?  \n● Are the oncometabolite-induced phenotypes selected adaptively or exaptively?  \nONCOMETABOLITES AND THEIR ORIGIN  \nIn cancer, metabolic pathways can be perturbed by genetic mutations, alterations in gene expression and/or protein modiﬁcations, leading to the accumulation of intermediate metabolites (Fig. 1), which are globally referred to as “oncometabolites”. Oncometabolites do not represent aberrant metabolites (with the partial exception of 2-hydroxyglutarate, to be described later) . They are actually standard","cbCaigbpvPtll76L","https://ap.wps.com/l/cbCaigbpvPtll76L","pdf",1563960,13,"English","# Evolution, heterogeneity, and Evo/Eco indexes\n## Metabolic alterations and oncometabolites at the crossroads\n## Mechanisms linking oncometabolites to evolvability\n# Facts and open questions\n# Oncometabolites and their origin","[{\"question\":\"What do the Evo and Eco indexes describe in cancer evolvability?\",\"answer\":\"The Evo index addresses cancer cell-autonomous heterogeneity at genetic and epigenetic levels. The Eco index describes the ecological landscape, including hazards to survival and available resources in the microenvironment.\"},{\"question\":\"How do oncometabolites connect genetic, epigenetic, and ecological alterations?\",\"answer\":\"Altered metabolism leads to accumulation of oncometabolites that were first viewed as mediators of microenvironmental changes. They are now recognized as inducers of genetic and epigenetic modifications, uniquely linking Evo and Eco components.\"},{\"question\":\"Which oncometabolites are emphasized, and how do they arise?\",\"answer\":\"The review focuses on lactate (L and D), fumarate, succinate, and 2-hydroxyglutarate (L and D). They originate from perturbations in energy-producing metabolism, such as glycolysis and the TCA cycle, driven by oncogenes or tumor suppressors and metabolic enzyme alterations.\"}]","Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer | PDF",1790017749,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63fbcbb0d2ae4d48c5f4ec60148532c3.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67e100843dca01600018c5c03dca7374.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a558cf194e1658700bd822a4fe614aa.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fa7b8e982481035d4ec766ad0f64ed7.webp",980,1301]